Table 5. Engraftment and chimerism after... | American Society of Hematology

Table 5.

Engraftment and chimerism after non-myeloablative stem cell transplantation

Patient	Cell dose (108/kg)	Neut >0.5 (days)	PI >20 (days)	Months post-BMT	% Donor whole blood	% Donor PBMNC	% Donor gran
1	2.5	9	13	1	100	100	100
				2	95	90-95	95
				3	95	95	95
				6	90	90	90
				9	85	90	85
				12	90	90	85
				16	75
2	1.3	13	14	1	100	100	100
				2	100	100	100
				3	100	100	100
				6	100	100	100
				15	100	100	100
3	6	13	10	1	100	100	100
				2	100	100	100
				3	100	100	100
				6	100	100	100
				9	100	100	100
				14	100	100	100
4	1.7	15	36	1	100	100	100
				2	90-95
				3	80	80
5	4.4	13	36	1		75	95
				2		55	85
				3		15	10
				4		25	5
				5		30	5
				8		45	5
				12		50	5
6	6.6	13	29	1	100	100	100
				2	100	100	100
				3	100	100	100
				5	100	100	100
				8	100	100	100
				12	100	100	100
7	3.1	17	15	1	100	100	100
				2	90
				3	80	80	75
				4	45	60	45
				5	55	50	60
				7	60	45	55
				9	55
8	1.4	13	37	1	100	100	100
				2	100	100	100
				3	100	100	100
				6	100	100	100
		X = 13	X = 22

Patient	Cell dose (108/kg)	Neut >0.5 (days)	PI >20 (days)	Months post-BMT	% Donor whole blood	% Donor PBMNC	% Donor gran
1	2.5	9	13	1	100	100	100
				2	95	90-95	95
				3	95	95	95
				6	90	90	90
				9	85	90	85
				12	90	90	85
				16	75
2	1.3	13	14	1	100	100	100
				2	100	100	100
				3	100	100	100
				6	100	100	100
				15	100	100	100
3	6	13	10	1	100	100	100
				2	100	100	100
				3	100	100	100
				6	100	100	100
				9	100	100	100
				14	100	100	100
4	1.7	15	36	1	100	100	100
				2	90-95
				3	80	80
5	4.4	13	36	1		75	95
				2		55	85
				3		15	10
				4		25	5
				5		30	5
				8		45	5
				12		50	5
6	6.6	13	29	1	100	100	100
				2	100	100	100
				3	100	100	100
				5	100	100	100
				8	100	100	100
				12	100	100	100
7	3.1	17	15	1	100	100	100
				2	90
				3	80	80	75
				4	45	60	45
				5	55	50	60
				7	60	45	55
				9	55
8	1.4	13	37	1	100	100	100
				2	100	100	100
				3	100	100	100
				6	100	100	100
		X = 13	X = 22